Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Mortgage borrowers will be to reduce term, change lenders through new FCA reforms

(Sharecast News) - The UK financial regulator is to introduce a package of reforms to simplify mortgage rules in an effort to help borrowers remortgage easier. The package of measures is aimed to "help people navigate their financial lives and support growth", by giving people more choice in the market, according to a statement by the Financial Conduct Authority on Monday evening.

Under the changes proposed, borrowers will be able to reduce their mortgage term easier to lower the overall cost of borrowing, and face fewer restrictions when remortgaging with a new lender to open up access to cheaper products.

The reforms, which are part of a wider mortgage rule review, are said to be voluntary for firms, though the regulator will "encourage firms to use these flexibilities" to broaden access and strengthen competition.

"We are helping more people navigate their financial lives by supporting those who can afford to buy a home and supporting competition in the mortgage market," said Emad Aladhal, director of retail banking at the FCA.

"Consumer needs have changed over recent years, and our rules are changing too. Today's changes support growth by simplifying some of our rules, saving consumers time and money, while ensuring they still benefit from advice, where needed."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.